UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020977
Receipt number R000024207
Scientific Title preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study
Date of disclosure of the study information 2016/04/01
Last modified on 2021/08/15 22:17:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study

Acronym

Preoperative chemoradiation therapy for pancreatic cancer

Scientific Title

preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study

Scientific Title:Acronym

Preoperative chemoradiation therapy for pancreatic cancer

Region

Japan


Condition

Condition

resectable and borderline resectable pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety of preoperative gemcitabine based chemoradiation therapy for pancreatic cancer.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

occurrence of side effect of preoperative gemcitabine based chemoradiation therapy

Key secondary outcomes

postoperative complication, 2-year recurrence-free survival, 2-year overall survival, recurrence site


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Other

Interventions/Control_1

gemcitabine (1000mg/m2) treated on day1,8,15,29,36,43,57,64,71

radiation thrapy;54gly(1.8Gly * 30days)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) histopathologically diagnosed pancreatic cancer
2) performance status: 0-1 (eco grade)
3) pancreatic cancer, diagnosed as resectable by enhanced computed tomography
4) patient who expected to have more than 6 month survival at start of the treatment
5) patient with normal organ function
white blood cell:>3500/mm3,<10,000/mm3
neutrophil: >2,000/mm3
lymphocyte: >1,500/mm3
platelet: >100,000/mm3
hemoglobin: >9.0g/dl
total bilirubin: <2.0mg/dl
ast, alt:>150 u/l
serum creatinine:<1.2mg/dl

Key exclusion criteria

1) unresectable pancreatic cancer
1 distant organ metastasis
2 peritoneal dissamination
3 para aortic lymph node metastasis
4 pancreatic cancer with artery invasion, such as abdominal aorta, superior mesenteric artery, ceriac artery, common hepatic artery, or proper hepatic artery.
5 portal vein invasion beyond reconstruction

patient with interstitial lung disease or fibroid lung

patient with severe diarrhea

active viral infection excluding viral hepatitis

patient with double cancer

a woman of childbearing potential

patient with severe psychological disorder

patient with severe allergy to any drug




Target sample size

10


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Marubashi

Organization

Fukushima medical university

Division name

Division of Hepato-Biliary-Pancreatic and Transplant surgery

Zip code

9601295

Address

fukushima hikarigaoka 1

TEL

024-547-1111

Email

mgotoh@fmu.ac.jp


Public contact

Name of contact person

1st name Naoya
Middle name
Last name sato

Organization

Fukushima medical university

Division name

Division of Hepato-Biliary-Pancreatic and Transplant surgery

Zip code

9601295

Address

fukushima hikarigaoka 1

TEL

024-547-1111

Homepage URL


Email

nawoya2U@gmail.com


Sponsor or person

Institute

fukushima medical university

Institute

Department

Personal name



Funding Source

Organization

fukusima medical university
department of regenerative surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima medical university

Address

Fukushima Hikarigaoka-1

Tel

0245471254

Email

nawoya@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福島県立医科大学附属病院


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 02 Month 10 Day

Date of IRB

2016 Year 04 Month 01 Day

Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2021 Year 02 Month 01 Day

Date of closure to data entry

2021 Year 02 Month 28 Day

Date trial data considered complete

2021 Year 10 Month 01 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 10 Day

Last modified on

2021 Year 08 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024207


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name